ID |
iron deficiency |
IDA |
Iron-deficiency anaemia |
GBD |
Global Burden of Disease |
CKD |
chronic kidney disease |
ACD |
Anemia of Chronic Disease |
IBD |
inflammatory bowel disease |
IV |
intravenous |
EPO |
erythropoietin |
ESA |
erythropoietin stimulating agent |
rHuEPO |
recombinant human erythropoietin |
FPN |
ferroportin |
DMT1 |
divalent metal transporter |
Dcytb |
duodenal cytochrome b |
MCV |
mean corpuscular volume |
Hb |
haemoglobin |
BMP |
bone morphogenic protein |
HJV |
hemojuvelin |
SMAD |
Mothers Against Decapentaplegic |
JAK2 |
Janus kinase 2 |
STAT 3 |
Signal transducer and activator of transcription 3 |
GDF 15 |
growth differentiation factor 15 |
PDGF-BB |
platelet-derived growth factor-BB |
HIF |
hypoxia-inducible factor |
VEGF |
vascular endothelial growth factor |
IL |
Interleukin |
FCF23 |
fibroblast growth factor |
KDIGO |
Kidney Disease: Improving Global Outcomes |
CHOIR |
Correction of Haemoglobin and Outcomes in Renal Insufficiency |
CREATE |
Cardiovascular Risk Reduction by Early Anemia Treatment |
TREAT |
Trial to Reduce Cardiovascular Events with Aranesp |
HIF-PHDI |
Hypoxia-Inducible factor Prolyl Hydroxylase Inhibitor |
|
|